05 Compliance

The regulatory file for low-MW hyaluronic acid

Technical document 05 · Reviewed 2026-11-20 · Hyaluronic Acid Low MW

On this page
  1. Four checks, one file
  2. European Union
  3. United States
  4. Contaminants and grade limits
  5. Label and claims
  6. Documents for the file
  7. Checklist before the first order

Low-molecular-weight hyaluronic acid can be sold as a supplement ingredient, but no single document makes that lawful. The source and the hydrolysis step behind the grade, the novel-food position, the contaminant ceilings, the label name and the claim are separate checks, and the buyer's regulatory team confirms the route for the destination. This page lists what belongs in the file; it is a sourcing reference, not legal advice.

In one line

The specification describes the powder; the file has to show the source, the grade, the market route and the label for the destination.

Four checks, one file

These questions do not collapse into one another. A lot can pass a metals limit and still carry wording the market forbids, and the same powder can be lawful in one country and not in another when the source or the process history changes. The company that places the supplement on the market carries the assessment; a certificate supports it but cannot replace it.

The grade adds a fifth item: the hydrolysis step that produces the 20–80 kDa band is part of the process description, and a regulatory conclusion tied to a different process does not automatically cover it. Record the step, the source and the molecular-weight method in the specification, then check the destination file against that description rather than against the product name alone.

European Union

Food supplements in the EU sit under Directive 2002/46/EC, which harmonises the category and lists the vitamins and minerals, with their permitted forms, in Annex II. Hyaluronic acid is outside that list, so the annex does not cover it; the ingredient is governed by general food law and the supplement labelling rules, and the operator still has to establish that the use is safe and lawful.

The novel-food position depends on how the material is made. As of this review, a 2023 Article 4 consultation under Regulation (EU) 2015/2283 found that sodium hyaluronate from fermentation with a non-genetically modified Streptococcus equi subsp. zooepidemicus strain is not a novel food when used in food supplements. The finding is tied to the process and use described; a hydrolysed low-molecular-weight grade made by a different step, a tissue-derived material, or the acid form rather than the salt needs its own review. The catalog article is named as hyaluronic acid, so the file should say which form the finding covers before anyone relies on it. Rooster comb extract follows a separate authorisation under Commission Implementing Decision 2013/705/EU, with a 60–80% hyaluronic acid specification.

Regulation (EU) 2023/915 sets the contaminant ceilings: for food supplements, lead 3.0 mg/kg, cadmium 1.0 mg/kg and mercury 0.10 mg/kg. Arsenic has no harmonised EU maximum, so the buyer sets that limit. Labelling falls under Regulation (EU) No 1169/2011 and claims under Regulation (EC) No 1924/2006. Great Britain keeps a separate novel-food register and labelling regime, while Northern Ireland stays inside the EU rules, so the delivery address decides which file is in play.

United States

On the US side the framework is DSHEA. FDA does not license a supplement or its ingredients before sale, but manufacturing must follow the dietary supplement cGMP in 21 CFR 111, the label needs a Supplement Facts panel and adverse events must be reported. The file should hold an NDI notification or another documented basis for the ingredient.

One question needs its own memo: the drug exclusion. Hyaluronic acid has a history as an approved drug, and an article first approved in that category is outside the dietary ingredient definition unless it was sold as a supplement before the approval. The brand's team should record the basis it uses. A structure/function statement is permitted when it is truthful, substantiated and carries the DSHEA disclaimer; naming a disease turns it into a drug claim.

Contaminants and grade limits

Metals are judged in the finished product, not only in the drum. The table is a starting point for a supplement file; the destination text and the daily dose settle the final figure. Assay and molecular weight are specification limits rather than regulatory ceilings, but they are what defines the grade in the file.

Limits to confirm for a low-MW hyaluronic acid file
ParameterCatalog limitEU supplement ceilingWhat the file should show
Lead (Pb)≤3 mg/kg3.0 mg/kgLot result, method and finished-product calculation
Cadmium (Cd)≤1 mg/kg1.0 mg/kgLot result and any category exception
Mercury (Hg)≤0.1 mg/kg0.10 mg/kgLot result and method
Arsenic (As)≤2 mg/kgNo harmonised limitAgreed limit and method, stated on the certificate
Assay and grade≥95.0%; 20–80 kDaNot a regulatory limitResult, basis, method and the label claim the number supports
Moisture and protein≤10.0%; ≤0.1%Not a regulatory limitResults that support the stability and purity story

Label and claims

On the label, the ingredient has to be named as the article that was bought. “Hyaluronic acid” and “sodium hyaluronate” are different names, and a label that uses the salt name for the acid article, or the reverse, has a mismatch between the specification and the artwork. The grade wording is a second layer: “low molecular weight” is a descriptor or a commercial claim, and it needs the molecular-weight result and method behind it.

At the time of this review the EU register contains no authorised claim for hyaluronic acid, so only claims on the applicable register are available; a grade descriptor is not a health claim, but it must not mislead. A US structure/function statement needs substantiation and the DSHEA disclaimer. Neither market permits a disease claim, and this page makes no health claim.

Documents for the file

Documents a low-MW hyaluronic acid file should contain
DocumentWhat it showsWhen it is needed
Batch COAAssay, molecular weight, moisture, protein, contaminants and microEvery lot
Specification and TDSRanges, methods and the grade bandEvery supplier qualification
Source and process statementFermentation or tissue route; hydrolysis step; production organismEvery lot, all markets
Novel-food determinationThe Article 4 conclusion or authorisation for that routeEU and NI files; GB register check
Contaminant and micro resultsIndividual element figures and countsEvery lot
Label and claim fileIngredient name, amount, grade wording and claim supportBefore the first print run
GMP or HACCP certificateThe control system behind the plantBefore approval; at audit

Checklist before the first order

  • The grade band, the form and the CAS number are named on the specification and the certificate.
  • The hydrolysis step and the source route are recorded, and the novel-food position is checked against them.
  • Each metal result is read against the destination ceiling rather than a “conforms” stamp.
  • The label name matches the article and the market file; the grade wording has a result behind it.
  • The claim wording has been reviewed for the destination, and no disease claim is present.
  • Quotation, specification and certificate all name the same revision.

The market notes are on the EU and US regulatory pages. The COA page explains the batch lines; identity and grade evidence are on the identity page; the catalog specification is on the product page. The quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation